Human Papilloma virus (HPV) infection is the most important risk factor. [20] It has been shown recently that cervical cancer is strongly associated with the presence of high risk or oncogenic Human Papilloma virus (HPV) types (up to 100%). [21, 22] Cervical cancer is a potentially a preventable disease through early detection using several screening techniques. [23] Therefore, the main focus is on the secondary prevention through early detection which is mainly done by cytology. This will lead to treatment of precancerous lesion itself before cancer develops hence reducing the incidence of cervical cancer. [24] In Screening by cytology we look for pre-cancerous changes in the cervix that could develop into cervical cancer. [3] Cytomorphologically abnormal epithelial cells are best demonstrated by the Papanicolaou test. The initial and most important step in cervical cancer screening was the introduction of Papanicolaou (Pap) testing [25, 26] . The 2014 Bethesda System has been introduced recently, which is used for reporting cervical smear in our study. 
Materials and Methods
This study was conducted in Department of Pathology, Mahatma Gandhi Medical College and Maharaja Yeshwant Rao Hospital, Indore, Madhya Pradesh, India. It is a prospective study. The study duration was one year from July 2017 to June 2018 Sample size for the study was of 40 cases.
Inclusion Criteria
• Symptomatic Females after puberty having following signs and symptoms.  Signs and symptoms to be screened: as documented by FIGO (2009) [11] • Abnormal vaginal bleeding, such as bleeding after vaginal intercourse, bleeding after menopause, bleeding and spotting between periods, and having (menstrual) periods that are longer or heavier than usual. Bleeding after douching or after a pelvic exam may also occur. • Pain in the lower abdomen or pelvic region.
• An unusual discharge from the vagina − the discharge may contain some blood and may occur between your periods or after menopause. • Pain during intercourse.
• Any cervical mass seen per speculum, per vaginum or on radiology. • All the patients who are at risk of cervical cancer attending the gynecology OPD routinely.
Exclusion Criteria
 Females bleeding per vaginum at the time of procedure.  Patients who have used vaginal medication, vaginal contraceptives, or douches for 48 hours before the sample collection.  Women who have had their uterus and cervix removed in a hysterectomy.  Females who were pregnant at the time of screening.  Patients who have had intercourse the night before the appointment should be avoided.  Already diagnosed cases of cervical cancer by histopathology.
 All 40 selected women were examined per vaginally and by speculum after acquiring a detailed history and verbal consent from them. The woman was placed in dorsal lithotomy position. After proper positioning of the woman, cervix was viewed by introducing Sims' vaginal speculum and anterior vaginal retractor and external os was identified. Pap smears were made by introducing cervical brush/ cytobrush with a detachable head were inserted into the external os and rotating it through 360 degrees 8-10 times in clockwise direction near the squamo-columnar junction. The cellular material thus obtained was quickly, but gently smeared on a clean glass slide. The glass slide was then immediately put into the Coplin jar containing 95% ethanol which acted as a fixative. The prepared smears were then stained according to Papanicolaou's technique.  After staining, slides were mounted, screened under light microscope, and reported according to 2014 Bethesda system. Table 2 shows in the present study epithelial cell abnormality is 37.5%.
Results & Observation 1. Distribution of benign lesion and epithelial cell abnormalities
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Graph 2 Distribution of NILM and Epithelial cell abnormality. 
Discussion
The present study comprised of taking cervical samples of 40 symptomatic women attending the outpatient department of Obstretric & Gynaecology.
Our study revealed ASCUS (17.5%) to be the most common epithelial cell abnormality. Similar results were obtained in other studies which also concluded that ASCUS to be the most common epithelial cell abnormality [27, 28] . ASCUS progresses to LSIL, HSIL and SCC. AGUS progresses to adenocarcinoma. [29, 30] Table No . 4 shows that the bulk of patient 29 (72.5%) belong to age group 21-40 years. Table no. 5 shows that low grade squamous intraepithelial lesion (LSIL) was found in 4 cases (10.0%). It was mainly in the age group 21-30 years. Invasive carcinoma cervix was found in 2 cases (5.0%). It was mainly in the age group 51-60 years.
Age incidence of epithelial cell abnormality by various authors-AUTHORS AGE (in years) Sunita A. Bamanikar et.al. [31] (2014) 20-75 years Hemali J. Tailor et.al. [32] The difference in the age incidence of intraepithelial lesions and carcinoma cervix could be due to wide variation in selection criteria. [33] 1974 19574 Asymptomatic (50%) Juneja et al. [34] 1993 67000 Bleeding P/V (65%) Manika Alexander [35] 2015 800 White discharge (72%) Our study 40 White discharge (62.5%) [36] (1986) Abnormal cytology was detected in 3.6% of the women in study group (gravid 3 para2 or more), which was significantly higher than the control (gravid 2 para1), indicating that the former are at higher risk of developing cervical cancer. Juneja A. [37] (1993), high incidence of cervical carcinoma in women with parity>2 was noted. Mishra NK et.al. [38] shows that higher parity groups (4 and above) had greater incidence of invasive carcinoma(6.7%) than those of lower parity groups (1.8%). Manika Alexander [39] (2015) showed that intraepithelial lesions and malignancy are Nulliparous 19.9% and Multiparous 80.1%. Women with large number of pregnancies usually start sexual life early and the early age of first intercourse might be etiologically more important than number of pregnancies. The period of early squamous metaplasia is the time of greatest risk for cellular transformation and for the development of cervical neoplasia. Early squamous metaplasia is most frequent in puberty, early adolescence and first pregnancy. Therefore, women who begin sexual activity at an early age when the metaplastic process is most active would have a greater chance of developing cervical cancer. In nulliparous women, cervical neoplasia is not very common. Hence multiparity is a high risk factor for the development of premalignant and malignant lesions, because of chronic infection, repeated birth trauma, poor personal care, poor nutrition and hygiene etc. Early marriages are still common in our country and hence exposure to coitus and repeated child births at an early age are also common. High parity usually means a young age at marriage and first pregnancy. One of the significant discrepancies between our study and the previously published data from other countries is the higher rate of ASCUS and lower rate of LSIL. We assume that as the women included in our study were routinely screened and/or re-screened, they presented with an early form of cytological interpretation in the cervical smear, and thus, ASCUS rate was higher. Most common age to develop carcinoma cervix is between 51-60 years and the precursor lesions occur 5 -10 years prior to developing invasive cancer. So a test which is detecting more women who are at risk for cervical carcinogenesis should be started as screening test so to drop down the incidence of deadly cervical cancer.
Conclusion
Cervical cytology is method for early detection of intraepithelial lesions and malignancy and therefore should be established as a routine diagnostic aid. The study reveals that the cases of cervical cancer can be detected at early stage if there are proper education and awareness in the society.
